Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 1,173 shares at $31.52 ($37K) on 2022-06-09, disclosed to the SEC on 2022-06-13.
Open-market sale of $37k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |